Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1994 Feb;93(2):684–691. doi: 10.1172/JCI117021

Prejunctional angiotensin II receptors. Facilitation of norepinephrine release in the human forearm.

B Clemson 1, L Gaul 1, S S Gubin 1, D M Campsey 1, J McConville 1, J Nussberger 1, R Zelis 1
PMCID: PMC293901  PMID: 8113403

Abstract

To determine if peripheral angiotensin II (Ang II) prejunctional receptors facilitating NE release exist in humans, we used [3H]NE kinetic methodology to measure forearm NE spillover during intrabrachial arterial Ang II infusions in eight normal male subjects. We used the following protocol to optimize conditions for demonstrating these receptors: (a) lower body negative pressure (-15 mmHg) to increase sympathetic nerve activity to skeletal muscle; and (b) intraarterial nitroprusside to maintain a high constant forearm blood flow (approximately 10 ml/min.100 ml) to maximize the proportion of neuronally released NE that spills over into the circulation. During lower body negative pressure, the following were infused intraarterially for three consecutive 20-min periods: saline, Ang II (4 ng/min), and Ang II (16 ng/min). During the Ang II infusions, forearm venous NE increased significantly from 173 to 189 and 224 pg/ml (P < 0.01), and forearm NE spillover increased from 384 to 439 and 560 ng/min.100 ml (P < 0.05 for high Ang II). Forearm NE clearance was unchanged. During low and high dose Ang II, the plasma venous Ang II concentrations were 25 and 97 pM, respectively. Since normal subjects increase plasma Ang II from 4 to 20-22 pM with exercise, standing, or diuretic administration, and patients with severe congestive heart failure can have a plasma Ang II of approximately 25 pM at rest, we suggest that Ang II might facilitate NE release in severe congestive heart failure, especially under conditions of stress.

Full text

PDF
685

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anand I. S., Ferrari R., Kalra G. S., Wahi P. L., Poole-Wilson P. A., Harris P. C. Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure. Circulation. 1989 Aug;80(2):299–305. doi: 10.1161/01.cir.80.2.299. [DOI] [PubMed] [Google Scholar]
  2. Baily R. G., Leuenberger U., Leaman G., Silber D., Sinoway L. I. Norepinephrine kinetics and cardiac output during nonhypotensive lower body negative pressure. Am J Physiol. 1991 May;260(5 Pt 2):H1708–H1712. doi: 10.1152/ajpheart.1991.260.5.H1708. [DOI] [PubMed] [Google Scholar]
  3. Baily R. G., Prophet S. A., Shenberger J. S., Zelis R., Sinoway L. I. Direct neurohumoral evidence for isolated sympathetic nervous system activation to skeletal muscle in response to cardiopulmonary baroreceptor unloading. Circ Res. 1990 Jun;66(6):1720–1728. doi: 10.1161/01.res.66.6.1720. [DOI] [PubMed] [Google Scholar]
  4. Broqvist M., Dahlström U., Karlberg B. E., Karlsson E., Marklund T. Neuroendocrine response in acute heart failure and the influence of treatment. Eur Heart J. 1989 Dec;10(12):1075–1083. doi: 10.1093/oxfordjournals.eurheartj.a059429. [DOI] [PubMed] [Google Scholar]
  5. Chang P. C., van der Krogt J. A., Vermeij P., van Brummelen P. Norepinephrine removal and release in the forearm of healthy subjects. Hypertension. 1986 Sep;8(9):801–809. doi: 10.1161/01.hyp.8.9.801. [DOI] [PubMed] [Google Scholar]
  6. Cleland J., Semple P., Hodsman P., Ball S., Ford I., Dargie H. Angiotensin II levels, hemodynamics, and sympathoadrenal function after low-dose captopril in heart failure. Am J Med. 1984 Nov;77(5):880–886. doi: 10.1016/0002-9343(84)90530-8. [DOI] [PubMed] [Google Scholar]
  7. Clemson B., Baily R. G., Davis D., Zelis R. Effects of desipramine on norepinephrine clearance in congestive heart failure. Am J Physiol. 1990 Aug;259(2 Pt 1):E261–E265. doi: 10.1152/ajpendo.1990.259.2.E261. [DOI] [PubMed] [Google Scholar]
  8. Daly P. A., Sole M. J. Myocardial catecholamines and the pathophysiology of heart failure. Circulation. 1990 Aug;82(2 Suppl):I35–I43. [PubMed] [Google Scholar]
  9. Davis D., Baily R., Zelis R. Abnormalities in systemic norepinephrine kinetics in human congestive heart failure. Am J Physiol. 1988 Jun;254(6 Pt 1):E760–E766. doi: 10.1152/ajpendo.1988.254.6.E760. [DOI] [PubMed] [Google Scholar]
  10. Esler M., Jennings G., Lambert G., Meredith I., Horne M., Eisenhofer G. Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol Rev. 1990 Oct;70(4):963–985. doi: 10.1152/physrev.1990.70.4.963. [DOI] [PubMed] [Google Scholar]
  11. Ferguson D. W., Berg W. J., Sanders J. S. Clinical and hemodynamic correlates of sympathetic nerve activity in normal humans and patients with heart failure: evidence from direct microneurographic recordings. J Am Coll Cardiol. 1990 Nov;16(5):1125–1134. doi: 10.1016/0735-1097(90)90544-y. [DOI] [PubMed] [Google Scholar]
  12. Francis G. S., Benedict C., Johnstone D. E., Kirlin P. C., Nicklas J., Liang C. S., Kubo S. H., Rudin-Toretsky E., Yusuf S. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation. 1990 Nov;82(5):1724–1729. doi: 10.1161/01.cir.82.5.1724. [DOI] [PubMed] [Google Scholar]
  13. Francis G. S., Goldsmith S. R., Levine T. B., Olivari M. T., Cohn J. N. The neurohumoral axis in congestive heart failure. Ann Intern Med. 1984 Sep;101(3):370–377. doi: 10.7326/0003-4819-101-3-370. [DOI] [PubMed] [Google Scholar]
  14. Galla J. H., Schneider G., Kotchen T. A., Hayslett J. P. Renin and aldosterone in the cardiomyopathic hamster in congestive heart failure. Endocrinology. 1977 Aug;101(2):389–395. doi: 10.1210/endo-101-2-389. [DOI] [PubMed] [Google Scholar]
  15. Goldsmith S. R., Hasking G. J., Miller E. Angiotensin II and sympathetic activity in patients with congestive heart failure. J Am Coll Cardiol. 1993 Apr;21(5):1107–1113. doi: 10.1016/0735-1097(93)90232-p. [DOI] [PubMed] [Google Scholar]
  16. Grossman E., Chang P. C., Hoffman A., Tamrat M., Kopin I. J., Goldstein D. S. Tracer norepinephrine kinetics: dependence on regional blood flow and the site of infusion. Am J Physiol. 1991 May;260(5 Pt 2):R946–R952. doi: 10.1152/ajpregu.1991.260.5.R946. [DOI] [PubMed] [Google Scholar]
  17. Guo G. B., Abboud F. M. Angiotensin II attenuates baroreflex control of heart rate and sympathetic activity. Am J Physiol. 1984 Jan;246(1 Pt 2):H80–H89. doi: 10.1152/ajpheart.1984.246.1.H80. [DOI] [PubMed] [Google Scholar]
  18. Hasking G. J., Esler M. D., Jennings G. L., Burton D., Johns J. A., Korner P. I. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation. 1986 Apr;73(4):615–621. doi: 10.1161/01.cir.73.4.615. [DOI] [PubMed] [Google Scholar]
  19. Hilgers K. F., Veelken R., Rupprecht G., Reeh P. W., Luft F. C., Mann J. F. Angiotensin II facilitates sympathetic transmission in rat hind limb circulation. Hypertension. 1993 Mar;21(3):322–328. doi: 10.1161/01.hyp.21.3.322. [DOI] [PubMed] [Google Scholar]
  20. Johnson J. M., Rowell L. B., Niederberger M., Eisman M. M. Human splanchnic and forearm vasoconstrictor responses to reductions of right atrial and aortic pressures. Circ Res. 1974 Apr;34(4):515–524. doi: 10.1161/01.res.34.4.515. [DOI] [PubMed] [Google Scholar]
  21. Kaufman L. J., Vollmer R. R. Endogenous angiotensin II facilitates sympathetically mediated hemodynamic responses in pithed rats. J Pharmacol Exp Ther. 1985 Oct;235(1):128–134. [PubMed] [Google Scholar]
  22. Leimbach W. N., Jr, Wallin B. G., Victor R. G., Aylward P. E., Sundlöf G., Mark A. L. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation. 1986 May;73(5):913–919. doi: 10.1161/01.cir.73.5.913. [DOI] [PubMed] [Google Scholar]
  23. Majewski H. Angiotensin II and noradrenergic transmission in the pithed rat. J Cardiovasc Pharmacol. 1989 Oct;14(4):622–630. doi: 10.1097/00005344-198910000-00014. [DOI] [PubMed] [Google Scholar]
  24. Phillips M. I. Functions of angiotensin in the central nervous system. Annu Rev Physiol. 1987;49:413–435. doi: 10.1146/annurev.ph.49.030187.002213. [DOI] [PubMed] [Google Scholar]
  25. Randall R. D., Zimmerman B. G. Abolition of long-term vascular influence of renin-angiotensin system. Am J Physiol. 1990 Aug;259(2 Pt 2):H543–H553. doi: 10.1152/ajpheart.1990.259.2.H543. [DOI] [PubMed] [Google Scholar]
  26. Rea R. F., Wallin B. G. Sympathetic nerve activity in arm and leg muscles during lower body negative pressure in humans. J Appl Physiol (1985) 1989 Jun;66(6):2778–2781. doi: 10.1152/jappl.1989.66.6.2778. [DOI] [PubMed] [Google Scholar]
  27. Riegger A. J., Liebau G. The renin-angiotensin-aldosterone system, antidiuretic hormone and sympathetic nerve activity in an experimental model of congestive heart failure in the dog. Clin Sci (Lond) 1982 May;62(5):465–469. doi: 10.1042/cs0620465. [DOI] [PubMed] [Google Scholar]
  28. Schwieler J. H., Kahan T., Nussberger J., Johansson M. C., Hjemdahl P. Influence of angiotensin II, alpha- and beta-adrenoceptors on peripheral noradrenergic neurotransmission in canine gracilis muscle in vivo. Acta Physiol Scand. 1992 Aug;145(4):333–343. doi: 10.1111/j.1748-1716.1992.tb09373.x. [DOI] [PubMed] [Google Scholar]
  29. Seidelin P. H., Coutie W. J., Struthers A. D. The effect of angiotensin II on endogenous noradrenaline release in man. Br J Clin Pharmacol. 1987 Dec;24(6):699–704. doi: 10.1111/j.1365-2125.1987.tb03234.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Starke K. Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol. 1977;77:1–124. doi: 10.1007/BFb0050157. [DOI] [PubMed] [Google Scholar]
  31. Starke K., Schümann H. J. Interactions of angiotensin, phenoxybenzamine and propranolol on noradrenaline release during sympathetic nerve stimulation. Eur J Pharmacol. 1972 Apr;18(1):27–30. doi: 10.1016/0014-2999(72)90127-6. [DOI] [PubMed] [Google Scholar]
  32. Starke K., Werner U., Schümann H. J. Wirkung von Angiotensin auf Funktion und Noradrenalinabgabe isolierter Kaninchenherzen in Ruhe und bei Sympathicusreizung. Naunyn Schmiedebergs Arch Pharmakol. 1969;265(2):170–186. [PubMed] [Google Scholar]
  33. Sundlöf G., Wallin B. G. Effect of lower body negative pressure on human muscle nerve sympathetic activity. J Physiol. 1978 May;278:525–532. doi: 10.1113/jphysiol.1978.sp012322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Swedberg K., Eneroth P., Kjekshus J., Wilhelmsen L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation. 1990 Nov;82(5):1730–1736. doi: 10.1161/01.cir.82.5.1730. [DOI] [PubMed] [Google Scholar]
  35. Tidgren B., Hjemdahl P., Theodorsson E., Nussberger J. Renal neurohormonal and vascular responses to dynamic exercise in humans. J Appl Physiol (1985) 1991 May;70(5):2279–2286. doi: 10.1152/jappl.1991.70.5.2279. [DOI] [PubMed] [Google Scholar]
  36. Tidgren B., Hjemdahl P., Theodorsson E., Nussberger J. Renal responses to lower body negative pressure in humans. Am J Physiol. 1990 Oct;259(4 Pt 2):F573–F579. doi: 10.1152/ajprenal.1990.259.4.F573. [DOI] [PubMed] [Google Scholar]
  37. Turini G. A., Waeber B., Brunner H. R. The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril. Eur Heart J. 1983 Jan;4 (Suppl A):189–197. doi: 10.1093/eurheartj/4.suppl_a.189. [DOI] [PubMed] [Google Scholar]
  38. Victor R. G., Leimbach W. N., Jr Effects of lower body negative pressure on sympathetic discharge to leg muscles in humans. J Appl Physiol (1985) 1987 Dec;63(6):2558–2562. doi: 10.1152/jappl.1987.63.6.2558. [DOI] [PubMed] [Google Scholar]
  39. Watkins L., Jr, Burton J. A., Haber E., Cant J. R., Smith F. W., Barger A. C. The renin-angiotensin-aldosterone system in congestive failure in conscious dogs. J Clin Invest. 1976 Jun;57(6):1606–1617. doi: 10.1172/JCI108431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Webb D. J., Seidelin P. H., Benjamin N., Collier J. G., Struthers A. D. Sympathetically mediated vasoconstriction is augmented by angiotensin II in man. J Hypertens Suppl. 1988 Dec;6(4):S542–S543. doi: 10.1097/00004872-198812040-00170. [DOI] [PubMed] [Google Scholar]
  41. Zelis R., Mason D. T., Braunwald E. A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failure. J Clin Invest. 1968 Apr;47(4):960–970. doi: 10.1172/JCI105788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Zimmerman B. G., Sybertz E. J., Wong P. C. Interaction between sympathetic and renin-angiotensin system. J Hypertens. 1984 Dec;2(6):581–587. doi: 10.1097/00004872-198412000-00002. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES